Publicaciones (32) Publicaciones en las que ha participado algún/a investigador/a

2012

  1. Adjustment disorders in primary care: Prevalence, recognition and use of services

    British Journal of Psychiatry, Vol. 201, Núm. 2, pp. 137-142

  2. Alternativas comunitarias a la hospitalización de agudos para pacientes psiquiátricos graves

    Actas Espanolas de Psiquiatria, Vol. 40, Núm. 6, pp. 323-332

  3. Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: Implications for neuropathic pain

    Pain, Vol. 153, Núm. 7, pp. 1438-1449

  4. Antioxidant defense system and family environment in adolescents with family history of psychosis

    BMC Psychiatry, Vol. 12

  5. Budgetary impact analysis of buprenorphine-naloxone combination (suboxone®) in Spain

    Health Economics Review, Vol. 2, Núm. 1, pp. 1-9

  6. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes

    Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 66-72

  7. Comparison of the antinociceptive effects of ibuprofen arginate and ibuprofen in rat models of inflammatory and neuropathic pain

    Life Sciences, Vol. 90, Núm. 1-2, pp. 13-20

  8. Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study

    Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 58-65

  9. Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression

    Anesthesiology, Vol. 117, Núm. 3, pp. 613-625

  10. EVITAL: A preliminary taxonomy and electronic toolkit of health-related habits and lifestyle

    The Scientific World Journal, Vol. 2012

  11. Efectos asociados al policonsumo de drogas en fiestas rave

    Health and addictions: salud y drogas, Vol. 12, Núm. 1, pp. 37-59

  12. El deseo y el poder: problemas del discurso de la medicina basada en la evidencia aplicado a salud mental

    Revista de la Asociación Española de Neuropsiquiatría, Vol. 32, Núm. 114, pp. 305-320

  13. Elucidating the mechanism of action of pregabalin: α 2δ as a therapeutic target in Anxiety

    CNS Drugs, Vol. 26, Núm. 8, pp. 637-648

  14. Family burden related to clinical and functional variables of people with intellectual disability with and without a mental disorder

    Research in Developmental Disabilities, Vol. 33, Núm. 3, pp. 796-803

  15. Identification and location of hot and cold spots of treated prevalence of depression in Catalonia (Spain)

    International Journal of Health Geographics, Vol. 11

  16. La narcolepsia

    MoleQla: revista de Ciencias de la Universidad Pablo de Olavide, Núm. 6, pp. 79-80

  17. Life satisfaction in persons with Intellectual Disabilities

    Research in Developmental Disabilities, Vol. 33, Núm. 4, pp. 1103-1109

  18. Medida de la eficiencia técnica de programas de tratamiento con opiáceos: utilidad del modelo Data Envelopment Analysis (DEA)

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 14, Núm. 3, pp. 79-88

  19. Person-centred medicine and mental health

    Epidemiology and Psychiatric Sciences, Vol. 21, Núm. 2, pp. 131-137

  20. Preclinical discovery of duloxetine for the treatment of depression

    Expert Opinion on Drug Discovery, Vol. 7, Núm. 8, pp. 745-755